Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort.

Lee J, Franovic A, Shiotsu Y, Kim ST, Kim KM, Banks KC, Raymond VM, Lanman RB.

Front Oncol. 2019 Apr 4;9:212. doi: 10.3389/fonc.2019.00212. eCollection 2019.

2.

Urine test for EGFR analysis in patients with non-small cell lung cancer.

Franovic A, Raymond VM, Erlander MG, Reckamp KL.

J Thorac Dis. 2017 Oct;9(Suppl 13):S1323-S1331. doi: 10.21037/jtd.2017.06.144. Review.

3.

Antitumor Activity of RXDX-105 in Multiple Cancer Types with RET Rearrangements or Mutations.

Li GG, Somwar R, Joseph J, Smith RS, Hayashi T, Martin L, Franovic A, Schairer A, Martin E, Riely GJ, Harris J, Yan S, Wei G, Oliver JW, Patel R, Multani P, Ladanyi M, Drilon A.

Clin Cancer Res. 2017 Jun 15;23(12):2981-2990. doi: 10.1158/1078-0432.CCR-16-1887. Epub 2016 Dec 23.

4.

MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment.

Wilson R, Espinosa-Diez C, Kanner N, Chatterjee N, Ruhl R, Hipfinger C, Advani SJ, Li J, Khan OF, Franovic A, Weis SM, Kumar S, Coussens LM, Anderson DG, Chen CC, Cheresh DA, Anand S.

Nat Commun. 2016 Nov 25;7:13597. doi: 10.1038/ncomms13597.

5.

Kinase-independent role for CRAF-driving tumour radioresistance via CHK2.

Advani SJ, Camargo MF, Seguin L, Mielgo A, Anand S, Hicks AM, Aguilera J, Franovic A, Weis SM, Cheresh DA.

Nat Commun. 2015 Sep 3;6:8154. doi: 10.1038/ncomms9154.

6.

Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescence.

Franovic A, Elliott KC, Seguin L, Camargo MF, Weis SM, Cheresh DA.

Cancer Res. 2015 Nov 1;75(21):4466-73. doi: 10.1158/0008-5472.CAN-15-0988. Epub 2015 Aug 21.

7.

Integrin αvβ3 drives slug activation and stemness in the pregnant and neoplastic mammary gland.

Desgrosellier JS, Lesperance J, Seguin L, Gozo M, Kato S, Franovic A, Yebra M, Shattil SJ, Cheresh DA.

Dev Cell. 2014 Aug 11;30(3):295-308. doi: 10.1016/j.devcel.2014.06.005.

8.

DNMT3a epigenetic program regulates the HIF-2α oxygen-sensing pathway and the cellular response to hypoxia.

Lachance G, Uniacke J, Audas TE, Holterman CE, Franovic A, Payette J, Lee S.

Proc Natl Acad Sci U S A. 2014 May 27;111(21):7783-8. doi: 10.1073/pnas.1322909111. Epub 2014 May 9.

9.

An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.

Seguin L, Kato S, Franovic A, Camargo MF, Lesperance J, Elliott KC, Yebra M, Mielgo A, Lowy AM, Husain H, Cascone T, Diao L, Wang J, Wistuba II, Heymach JV, Lippman SM, Desgrosellier JS, Anand S, Weis SM, Cheresh DA.

Nat Cell Biol. 2014 May;16(5):457-68. doi: 10.1038/ncb2953. Epub 2014 Apr 20.

10.

An oxygen-regulated switch in the protein synthesis machinery.

Uniacke J, Holterman CE, Lachance G, Franovic A, Jacob MD, Fabian MR, Payette J, Holcik M, Pause A, Lee S.

Nature. 2012 May 6;486(7401):126-9. doi: 10.1038/nature11055.

11.

A MEK-independent role for CRAF in mitosis and tumor progression.

Mielgo A, Seguin L, Huang M, Camargo MF, Anand S, Franovic A, Weis SM, Advani SJ, Murphy EA, Cheresh DA.

Nat Med. 2011 Nov 13;17(12):1641-5. doi: 10.1038/nm.2464.

12.

HIF-2alpha: many cancers, one engine?

Franovic A, Lee S.

Cell Cycle. 2010 Mar 1;9(5):859-60. Epub 2010 Mar 11. No abstract available.

PMID:
20348840
13.

ETS-1 oncogenic activity mediated by transforming growth factor alpha.

Holterman CE, Franovic A, Payette J, Lee S.

Cancer Res. 2010 Jan 15;70(2):730-40. doi: 10.1158/0008-5472.CAN-09-2090. Epub 2010 Jan 12.

14.

Human cancers converge at the HIF-2alpha oncogenic axis.

Franovic A, Holterman CE, Payette J, Lee S.

Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21306-11. doi: 10.1073/pnas.0906432106. Epub 2009 Dec 2.

15.

Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer.

Franovic A, Gunaratnam L, Smith K, Robert I, Patten D, Lee S.

Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13092-7. Epub 2007 Aug 1.

16.

Multiple acquired renal carcinoma tumor capabilities abolished upon silencing of ADAM17.

Franovic A, Robert I, Smith K, Kurban G, Pause A, Gunaratnam L, Lee S.

Cancer Res. 2006 Aug 15;66(16):8083-90.

17.

Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer.

Smith K, Gunaratnam L, Morley M, Franovic A, Mekhail K, Lee S.

Cancer Res. 2005 Jun 15;65(12):5221-30.

18.

Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells.

Gunaratnam L, Morley M, Franovic A, de Paulsen N, Mekhail K, Parolin DA, Nakamura E, Lorimer IA, Lee S.

J Biol Chem. 2003 Nov 7;278(45):44966-74. Epub 2003 Aug 27.

19.
20.

[Health knowledge in patients with rheumatic diseases].

Suncić S, Franović A, Lipovsek P.

Reumatizam. 1990;37(1-6):19-23. Croatian.

PMID:
2135453
21.

[Evaluation of the possibilities of supplementing or changing the exercise therapy performed by patients with ankylosing spondylitis by using kinesiologic elements of recreational sports].

Franović A, Vidmar J, Barac D, Facković D, Hudovsky G.

Reumatizam. 1985;32(3-4):55-61. Croatian. No abstract available.

PMID:
4070840
22.

[The long-term positive effects of educational-motivational care of patients with ankylosing spondylitis].

Franović A.

Reumatizam. 1985;32(1-2):10-6. Croatian. No abstract available.

PMID:
4023461
23.

[Total functional ability of patients with ankylosing spondylitis].

Franović A, Vidmar J, Hudovsky G, Facković D, Barac D.

Reumatizam. 1985;32(5-6):121-5. Croatian. No abstract available.

PMID:
3832216
24.

[Ankylosing spondylitis in a woman with cerebral palsy].

Franović A.

Reumatizam. 1982;29(1):15-8. Croatian. No abstract available.

PMID:
7079635
25.

[Atypical periarthritis or an unusual picture of a painful shoulder? (case report)].

Franović A, Vidmar J, Kocjan F.

Reumatizam. 1981;28(5):158-9. Croatian. No abstract available.

PMID:
7313371
26.

[The rheumatic patient - an equal member of his rehabilitation team].

Franovic A.

Reumatizam. 1981;28(1):1-10. Croatian. No abstract available.

PMID:
6974885
27.

[Education of rheumatic patients (author's transl)].

Franovic A.

Lijec Vjesn. 1980 Jul-Aug;102(7-8):349-53. Croatian. No abstract available.

PMID:
6974813
28.

[A critical review of modern methods of dosing in the functional treatment of ankylosing spondylitis].

Franović A.

Reumatizam. 1980;27(3):72-9. Croatian. No abstract available.

PMID:
7403712
29.

[Carpal tunnel syndrome during the course of rheumatoid arthritis].

Franović A.

Reumatizam. 1975;22(4):151-2. Croatian. No abstract available.

PMID:
1179060
30.

[Effectiveness of Voltaren and Brufen in rheumatic diseases].

Franović A.

Reumatizam. 1975;22(3):101-3. Croatian. No abstract available.

PMID:
1096255
31.

[Our 1st experiences with Butazolidin Alka 100 tablets].

Franović A.

Reumatizam. 1974 Jan;21(1):8-10. Croatian. No abstract available.

PMID:
4594966
32.

[Therapeutic use of clofezone in rheumatic diseases].

Vitaus M, Franovic A, Dürrigl T.

Schweiz Rundsch Med Prax. 1973 Jan 16;62(3):78-82. German. No abstract available.

PMID:
4282506
33.

[School board in the physician's office].

Franović A, Nanković V.

Reumatizam. 1966;13(6):218-9. Serbian. No abstract available.

PMID:
5298520

Supplemental Content

Loading ...
Support Center